ASPRIN provides protection against staphylococcus aureus infections

Print

 ASPRIN provides protection against
staphylococcus aureus infections

Lt. Gen. Mahmud Ahmad Akhtar

Now researchers have found another benefit of Asprin: protection against staphylococcus aureus infections. Coagulase positive staphylococcal infections are an important cause of death. This organism had developed resistance to many antibiotics- quite often needs very expensive highly specialized third generationcephalosporin antibiotics beyond the reach of over 70% of population. Resistant Infection has become a serious problem in hospital settings- more so in Pakistan where preventive measures are abysmally lacking and affordable. The conclusion is based on a study by life saving “Essential antibacterials”, cloxacillin, floucloxacillin are not available.

Swiss scientists who followed 838 cases of S. aureus infection from 2001 to 2013. From the group they selected 157 who were taking Aspirin and matched with 157 controls, similar in age, severity of infection, treatment undergone and various other health and behavioural problems but who were not taking low dose asprin. The study is in Critical Care Medicine.

At the end of 30 days, 27.4% of controls had died, but only 12.1% of those on aspirin had died. After controlling for other factors, taking low dose asprin was associated with 42% lower risk of death. This is a “retrospective study” said the lead author, Dr Micheal Osthoff of the University of Basel.

 In Pakistan due to poor hygienic and sanitary conditions resistant staphylococcal aureus infections are very common.Low dose Aspirin would be a good strategy to tackle this problem in Pakistan.Prevention is not only better than cure but the only real cure-very cost effective.

Ref. “International New York Times” Feb 10 2016.page 8.